ICI & Heart Damage: New Target to Prevent Cancer Therapy Side Effect
Hope for Reducing Immune-Related Heart Risks in Cancer Patients For millions battling cancer worldwide, immune checkpoint inhibitors (ICIs) have become a cornerstone of treatment, significantly extending lives. Drugs like Keytruda and Opdivo have become household names for those navigating complex cancer journeys. Still, this powerful therapy isn’t without risk. In some patients, ICIs can inadvertently … Read more